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Abstract
The forkhead transcription factor Foxn1 is indispensable for thymus development, but the mechanisms by which it mediates
thymic epithelial cell (TEC) development are poorly understood. To examine the cellular and molecular basis of Foxn1
function, we generated a novel and revertible hypomorphic allele of Foxn1. By varying levels of its expression, we identified
a number of features of the Foxn1 system. Here we show that Foxn1 is a powerful regulator of TEC differentiation that is
required at multiple intermediate stages of TE lineage development in the fetal and adult thymus. We find no evidence for a
role for Foxn1 in TEC fate-choice. Rather, we show it is required for stable entry into both the cortical and medullary TEC
differentiation programmes and subsequently is needed at increasing dosage for progression through successive
differentiation states in both cortical and medullary TEC. We further demonstrate regulation by Foxn1 of a suite of genes
with diverse roles in thymus development and/or function, suggesting it acts as a master regulator of the core thymic
epithelial programme rather than regulating a particular aspect of TEC biology. Overall, our data establish a genetics-based
model of cellular hierarchies in the TE lineage and provide mechanistic insight relating titration of a single transcription
factor to control of lineage progression. Our novel revertible hypomorph system may be similarly applied to analyzing other
regulators of development.
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Introduction
T cell development occurs in the thymus and depends on
progressive interactions with the thymic stroma. Critical to this
function is the thymic epithelium (TE), which comprises a diverse
array of phenotypically and functionally distinct cell types broadly
organized into cortical and medullary regions [1].
During development the thymus arises from the endoderm of the
third pharyngeal pouches [2] which, from day 9 of embryonic
development in the mouse (E9.0), contain cells specified to the TE
lineage [2]. Until E11.5, this region uniformly expresses the cell
surface determinant Plet-1 [3-5] and the earliest currently identified
founder cells for the lineage are thus Plet-1+ third pharyngeal
pouch cells. By E12.5 the thymic primordia, now colonized by
haematopoietic progenitor cells and surrounded by a mesenchymal
capsule, have separated from the pharyngeal endoderm and contain
a predominant EpCam+Plet1+ epithelial population [3,6,7]. Recent
evidence supports the existence within this population of a common
thymic epithelial progenitor cell (TEPC) capable of generating both
cortical and medullary TEC (cTEC and mTEC respectively) [7,8].
Further studies indicate that a medullary sub-lineage specific
progenitor cell is present at least as early as E13.5 [9,10], and
suggest the existence of a cortical sub-lineage specific progenitor
[11]. However, the extent to which these progenitor activities persist
in late organogenesis and the postnatal organ has not been
determined and furthermore, the timing of emergence of the sub-
lineage progenitors during organogenesis remains unclear.
The forkhead transcription factor Foxn1 [12], the gene mutated
in the classical mouse mutant nude (nu) [13], is a pivotal regulator of
TE lineage development. Nude mice are hairless and athymic
[14,15]. In Foxn1 null animals, the earliest stages of thymus
development appear to occur normally, but development is
arrested after initial formation of the organ primordium (around
E12.0 in the mouse) and the primordium is not colonized by
hematopoietic precursors [16]. Nonetheless, the Foxn1 null thymic
primordium separates from the parathyroid component of the
common primordium and migrates to the mid-line, where a small,
alymphoid cystic thymic remnant persists postnatally [14]. Null
alleles of Foxn1 in mouse, rat and human all exhibit essentially the
same pleiotropic phenotype [17].
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Forkhead family members play important roles in specification
and progression of a number of cell lineages, and recent evidence
reveals roles for some Forkhead proteins in chromatin modifica-
tion/epigenetic regulation of cell fate [18]. Analysis of postnatal
nude:wild-type chimeric mice demonstrated the cell autonomous
requirement for Foxn1 in development of all major TEC sub-
lineages and suggested that TE lineage cells unable to express
functional Foxn1 might undergo maturational arrest at a common
TEPC stage [19]. A revertible Foxn1 null model, Foxn1SA2/SA2
provided strong support for this hypothesis, as neonatal clonal
reversion of this allele resulted in the generation of small units of
functional thymus tissue containing both cortical and medullary
compartments [8]. Further support for a role in differentiation
comes from studies on keratinocytes, which implicate Foxn1 in
regulating initiation of terminal differentiation [20,21], and from
analysis of a hypomorphic Foxn1 allele which generates a transcript
lacking exon 3 and thus the N-terminal domain of Foxn1 [22]. In
mice homozygous for this allele (Foxn1D), the postnatal Foxn1D/D
thymus was highly cystic, contained no discernable cortical or
medullary regions and could sustain only highly impaired
thymocyte differentiation, suggesting that Foxn1 is actively
required for TEC differentiation at stages beyond initiation of
the TEC programme [22]. Evidence also supports roles for Foxn1
in TEC proliferation [23] and in regulating the balance between
proliferation and differentiation in skin [24]. In addition, a
requirement for Foxn1 for maintenance of the postnatal thymic
microenvironment has recently been demonstrated [25–27], with
evidence pointing to differential sensitivity of different TEC
subsets to changes in Foxn1 dosage [26]. Collectively, these studies
suggest that Foxn1 plays a complex role in regulating TEC lineage
development. However, precisely how Foxn1 regulates the transit
from the earliest fetal thymic epithelial progenitor cell to the fully
functional postnatal thymic epithelium, and at which stages in this
process it is required, remains undetermined. In addition, the
molecular mechanisms regulated by this transcription factor in the
thymus have not yet been addressed.
In this study, we have addressed the functions of Foxn1
throughout thymus ontogeny, via generation and analysis of a
novel revertible hypomorphic allele of Foxn1, Foxn1R, which
expresses only low levels of Foxn1 mRNA and protein. A
particular advantage of our system is the revertible nature of the
allele, which affords the capacity to test the relationship of cell
states identified via analysis of mutant mice to states occurring in
normal ontogeny. Our studies establish Foxn1 as a powerful
regulator of differentiation in both the cTEC and mTEC sub-
lineages. We find no evidence for a role for Foxn1 in regulating
cell fate choice in the cortical or medullary TEC sub-lineages.
Rather, we find that Foxn1 is required for progression of
differentiation at multiple stages in cTEC and mTEC sub-lineage
development in both the fetal and postnatal thymus, and show that
different Foxn1 dosage is required to execute its function(s) at
different differentiation stages. We further establish that Foxn1
regulates, either directly or indirectly, a suite of genes known to
effect TEC function - including Dll4, CCL25, Cathepsin L, CD40,
Pax1, and MHC Class II, and that these exhibit different response
patterns to changes in Foxn1 dosage. Collectively, these findings
significantly advance understanding of the role of Foxn1 in TEC,
demonstrating for the first time its direct involvement in
generating multiple TEC sub-types in both the cortical and
medullary lineages in the fetal and postnatal thymus, and
suggesting it acts effectively as a master regulator of the entire
TEC programme.
Results
Generation of a revertible hypomorphic allele of Foxn1
We set out to generate a conditionally revertible null allele of
Foxn1 as a tool for generating TEPC lines. Our rationale was that
lack of Foxn1 expression would impose an early block on TEC
lineage differentiation, effectively trapping TEC in an undifferen-
tiated progenitor cell state, while reversion of the allele would
remove this block and allow progression to terminal differentia-
tion. Since the extent to which Foxn1 is required for TEC
proliferation is unknown, SV40 T antigen was used to uncouple
potential roles of Foxn1 in proliferation and differentiation. We
thus generated the revertible Foxn1 allele, Foxn1R, by inserting a
LoxP flanked cassette into intron 1b of the Foxn1 locus by
homologous recombination in ES cells (Figure 1A, Figure S1) and
used this ES line to generate the Foxn1R mouse strain. Initial
characterization of postnatal Foxn1R/+ mice revealed thymus
hyperplasia as expected, due to expression of SV40 Tag under
the Foxn1 promoter. However, Foxn1R/R mice developed severely
hypoplastic thymi rather than exhibiting the expected phenotype
of complete thymic aplasia (Figure 1B). In keeping with this,
immunoblotting for Foxn1 revealed low-level Foxn1 protein in
Foxn1R/R thymi compared to wild-type (WT; Figure 1C) and RT-
PCR analyses demonstrated that the transcripts produced from
the Foxn1R allele contained either Exon1a-SV40Tag-IRES-eGFP-
neo elements or the full-length Foxn1 mRNA (Figure 1D). Thus
some residual Foxn1 expression from Foxn1R occurred, and resulted
from splicing around the targeted insertion subsequent to
transcription proceeding beyond the transcriptional pause. No
overt skin phenotypes were apparent in either Foxn1R/+ or Foxn1R/R
mice. Collectively, these data establish that Foxn1R is a hypomorphic
allele that expresses a low level of Foxn1 compared to WT and that
expression of SV40Tag does not compensate for decreased levels of
Foxn1.
The revertibility of the allele was demonstrated by crossing
Foxn1R/+ mice with the ZP3Cre deletor strain, in which Cre
recombinase is expressed in oocytes [28]. Foxn1R/+ZP3Cre/+ mice
excised the LoxP flanked cassette in most if not all cells (Figure 1E),
and showed normal thymus development and function.
Author Summary
The thymus is the specialized organ responsible for
generating T cells, which are required to regulate and
effect immune responses. The unique functions of the
thymus are mediated by a diverse array of specialized
epithelial cells found only within this organ. These
specialized, functionally mature thymic epithelial cells are
generated from immature epithelial progenitor cells
present in the fetal and adult thymus through a highly
regulated process, termed differentiation, that is tightly
controlled by specific genes. Foxn1, a protein that is
expressed in thymic epithelial cells, is a transcription
factor—a protein that regulates how other genes are
expressed. Here, we have investigated the role of Foxn1 in
generating mature thymic epithelial cells from immature
progenitors. We find that Foxn1 is required throughout
this process, from the onset of differentiation in progenitor
thymic epithelial cells in the developing fetus to the final
differentiation steps through which thymic epithelial cells
mature to acquire their full functionality. We further find
that Foxn1 controls the expression of a variety of genes
with different functions in thymic epithelial cells. Overall,
our study defines the role of Foxn1 in thymus develop-
ment at the cellular level and provides insight into how it
mediates these functions.
Foxn1 Regulation of Thymic Epithelial Cells
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SV40 T antigen does not affect TEC differentiation or
function in Foxn1R/+ thymi
The Foxn1 null phenotype of severe athymia results from a
complete early block in thymus development and has limited
understanding of the role of Foxn1 later in ontogeny. We reasoned
that the Foxn1R allele might be informative in this light. However,
it was first necessary to test whether expression of SV40Tag under
the Foxn1 promoter affected TEC differentiation or function.
Therefore, we characterized the Foxn1R/+ thymus phenotype, in
particular seeking evidence for impaired or perturbed TEC
development and/or function. The two thymic lobes in Foxn1R/+
mice exhibited a greater than ten-fold increase in both TEC and
thymocyte numbers compared to WT littermates (Figure 1), but
were otherwise histologically normal (Figure 1B, 1F). In both fetal
and postnatal Foxn1R/+ thymi, TEC and thymocyte subset
distributions were indistinguishable from Foxn1nu/+ and WT
littermates and no evidence of malignant transformation could
be found (Figure 1G-1I). We therefore concluded that the thymic
hyperplasia observed resulted from a uniform expansion of the
TEC compartment due to expression of SV40Tag under control
of the Foxn1 promoter, but that this did not affect TEC
differentiation or function in either the fetal or postnatal thymus.
This is consistent with the action of SV40TAg in a variety of other
tissues [29–31] and its known function in regulating cell
proliferation. Of note is that the Foxn1 promoter drives relatively
low levels of gene expression in TEC, based on QRT-PCR
analyses relative to a range of housekeeping genes. This
demonstrated that Foxn1 is expressed in the same range as alpha-
tubulin, which is recognized to be expressed at low levels [32]
(Figure S2). Furthermore, SV40Tag was not detectable by
immunohistochemical analysis of thymus sections from Foxn1R
mutant mice (Figure S2).
Figure 1. Foxn1R is a hypomorphic allele. (A) A LoxP flanked
cassette containing the 59 engrailed 2 splice acceptor site (SA), the
SV40TAg coding region, an internal ribosome entry site coupled to an
enhanced green fluorescent protein/neomycin resistance fusion protein
(IRES-EGFPneo), and the CMAZ transcriptional pause [65] was inserted
into intron 1b of the Foxn1 locus of mouse ES cells (Figure S1). E, exon.
(B) Images show representative pairs of thymic lobes from six week old
WT, Foxn1R/+ and Foxn1R/R as indicated. Scale bars represent 1cm.
Thymocyte numbers - Foxn1R/R, 5.0610762.36106; Foxn1R/+,
2.6x10969.56107; WT littermates 1.96108 68.16106. WT versus
Foxn1R/+ p=3.761026; WT versus Foxn1R/R p=2.061025, n = 3 for each
genotype. TEC numbers: WT, 1.3610668.46105; Foxn1R/+ ,
1.3610761.86106; Foxn1R/R, 3.6610562.16105. WT versus Foxn1R/+
p= 0.00054; WT versus Foxn1R/R p=0.09374. (C) Immunoblots per-
formed on nuclear extracts isolated from whole E12.5 thymus tissue
were probed sequentially with anti-Foxn1 (left panel) and anti-alpha-
tubulin (loading control; right panel). Arrows indicate bands corre-
sponding to Foxn1 and alpha-tubulin. Genotypes are indicated above
each image. WT, wild-type; R/+, Foxn1R/+; R/R, Foxn1R/R. (D) RT-PCR
analysis of Foxn1R/R TEC reveals splicing around the inserted cassette.
cDNA from whole adult thymus from wild type, Foxn1R/+ or Foxn1R/R
thymi was subjected to RT-PCR using primers specific for Foxn1 exon1a
(forward) and exon 3 (reverse); Foxn1 exon1a (forward) and SV40Tag
(reverse), or ß actin as shown. Lanes: m, markers; 1, wild type cDNA; 2,
wild type no RT control; 3, Foxn1R/+ cDNA; 4, Foxn1R/+ no RT control; 5,
Foxn1R/R cDNA; 6, Foxn1R/R no RT control. Bands in lanes 4 and 6 of the ß
actin panel are non-specific. Band specificity was confirmed by
sequencing. (E) Reversion of the Foxn1R allele in Foxn1R/+ZP3Cre/+ mice.
Foxn1R/+ males were mated with ZP3Cre/Cre females to generate Foxn1R/+:
ZP3Cre/+ mice. Foxn1R/+:ZP3Cre/+ females were then crossed with C57BL/6
males and the resulting offspring analyzed. Twomice (lanes 1 and 2) were
identified by PCR as carrying both the Foxn1R allele (using primers
specific for the targeted allele) and the ZP3Cre transgene and were
subsequently analyzed by Southern blotting of Nde1 digested genomic
DNA using a probe flanking the 39 end of the homology arms. In both
cases only a 7.5kb band was present indicating complete excision of the
targeted insertion. Lane 3 shows the 8.5kb and 7.5kb bands correspond-
ing to the targeted and WT alleles respectively in a Cre negative Foxn1R/+
littermate. (F-I) Morphological and phenotypic analysis of 6 week-old
Foxn1R/+ thymi. (F) Representative H&E staining showing overtly normal
architecture in Foxn1R/+ thymi. Magnification, x10. (G, I) Plots show flow
cytometric analysis of 6 week old Foxn1R/+ or WT thymi with markers
shown. Plots in I) show data after gating against CD45+ and on EpCam+
cells. (H) Immunohistochemical analysis showing normal staining
patterns with markers specific for medullary (K14, Aire) and cortical
(CDR1) TEC and for the TEC maturation marker MHC Class II (MHCII).
Epithelial cells are identified by co-staining with anti-pancytokeratin
(PanK) in lower and upper panels. Right panels show co-stains of left
panels, right AIRE panel shows detail from left panel. Scale bars 150 mm
except right Aire panel which is 11.9 mm. Data shown in F-I are
representative of at least three independent experiments. Thymocyte (G)
and TEC (H,I) subset distribution is indistinguishable between Foxn1R/+
and WT thymi.
doi:10.1371/journal.pgen.1002348.g001
Foxn1 Regulation of Thymic Epithelial Cells
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Terminal differentiation of postnatal cortical and
medullary TEC is blocked in Foxn1R/R mice
Next, we tested the effect of reduced Foxn1 dosage on postnatal
TEC by analyzing the Foxn1R/R phenotype. Although small,
Foxn1R/R thymi were grossly histologically normal, containing
clear cortical and medullary regions (Figure 2A, 2B). Postnatal
Foxn1R/R thymi contained all normal thymocyte subsets (Figure 2C,
2D). However, the CD4+8+ double positive (DP) subset was
proportionally larger than in WT littermates while the CD4+ and
CD8+ single positive (SP) subsets were proportionally reduced (DP
proportions: Foxn1R/R, 91.260.85%; WT 82.960.21%,
p= 0.0004) suggesting that the DP to SP transition and/or
subsequent thymocyte maturation was perturbed in Foxn1R/R
mice. The CD4-8- (Double negative, DN) cell subset distribution
was also altered in postnatal Foxn1R/R thymi, with increased
proportions of CD44+CD25- (DN1) and CD44-CD25+ (DN3) cells
(Figure 2D). Most DN1 cells in postnatal Foxn1R/R thymi were B
cells, as shown by B220 staining (Figure 2E), suggesting impaired
commitment of hematopoietic progenitors to the T cell lineage
[33,34]. Furthermore, thymocyte development was delayed in
Foxn1R/R mice early in ontogeny (Figure 2F). Thus, rather than
simply resulting from reduced numbers of functionally normal
TECs, the hypoplastic Foxn1R/R phenotype was characterized by
impaired TEC functionality.
Interrogation of TEC subset distribution and marker expression
in the Foxn1R/R thymus revealed apparently normal morphologies
for medullary and cortical TEC (mTEC and cTEC respectively),
and normal expression patterns for cytokeratin (K) 5, K8 and
CD205 (Figure 2B, Figure 3A and 3Ai), indicating the presence of
cortical and medullary compartments. Further analysis however
revealed abnormal gene expression patterns in both compart-
ments.
The cTEC marker CDR1 is acquired only postnatally in cTEC
and thus represents a terminal differentiation marker for this TEC
sub-lineage. Ly51 is another commonly used marker that is cTEC-
specific within the thymus. Expression of both of these markers
was severely down-regulated in Foxn1R/R thymi (Figure 3B-3Ci).
MHC class II, Cathepsin L and Dll4 are TEC markers with
known functions in thymocyte development [11,33–37]. MHC
Class II staining on Foxn1R/R cTEC was dramatically reduced
compared to Foxn1R/+ and WT littermates (Figure 3D and 3Di),
and similarly, Cathepsin L expression was down-regulated in
Foxn1R/R cTEC (Figure S3). Dll4 expression was dramatically
reduced on both fetal and postnatal Foxn1R/R TEC compared to
aged-matched WT controls (Figure 3E and 3Ei, see also Figure
S3). These data provide a possible explanation for the altered
thymocyte subset distributions present in Foxn1R/R mice.
CD40 is expressed on TEC and thymic dendritic cells and is
required for medullary development [38,39]. Expression of CD40
was also substantially down-regulated on postnatal Foxn1R/R cTEC
but was largely unaffected on mTEC (Figure 3F). Expression of the
recently identified cTEC-specific thymic proteasome subunit ß5t
[40] was affected only slightly if at all (Figure 3G and 3Gi;
proportion of TEC that are ß5t+: Foxn1R/R, twenty four percent;
WT, twenty four percent).
Aire is a key regulator of thymus function, and within the
thymus is specifically expressed in a subset of mTEC. Significantly
fewer Aire+ mTEC were present in Foxn1R/R compared to WT
thymi (Figure 3H and 3Hi).
Collectively, these data established that differentiation of both
cortical and medullary TECwas impaired in the postnatal thymus of
Foxn1R/R mutants. In particular, since cTEC morphology appeared
normal but several cTEC-specific markers were severely down-
regulated in Foxn1R/R thymi, they strongly suggested the hypothesis
that terminal differentiation was blocked in the cTEC sub-lineage.
Reversion to wild-type Foxn1 expression levels in Foxn1R/R
mice leads to rapid acquisition of terminal differentiation
phenotypes in cTEC and mTEC
To test whether this hypothesis was correct, or alternatively
whether the postnatal Foxn1R/R phenotype reflected the absence of a
normal cTEC population and/or overgrowth of a normally minor
TEC population, we bred a constitutively expressed tamoxifen
inducible Cre recombinase allele, ROSA26CreERt2 [41], onto the
Foxn1R/R background. We then tested the outcome of reverting the
Foxn1R allele via Cre-mediated excision of the LoxP-flanked cassette,
such that WT levels of Foxn1mRNA expression were restored. Thus,
adult Foxn1R/R; ROSA26CreERt2 mice were injected with 4-hydroxy
Figure 2. Functional deficit in Foxn1R/R TEC. Morphological and
phenotypic analysis of 6 week old Foxn1R/R thymi. (A) H&E staining
showing frequent large medullary cysts in Foxn1R/R thymi. (B)
Immunostaining with anti-cytokeratin 5 (K5) and anti-cytokeratin 8
(K8) showing overtly normal cortical and medullary compartments in
Foxn1R/R thymi; note the normal morphology of cortical and medullary
TEC. (C-E) Flow cytometric analysis of 6 week old wild-type or Foxn1R/R
thymocytes with (C) anti-CD4-PE, anti-CD8-FITC, (D) anti-CD44-APC and
anti-CD25-PE after gating on Lin- cells (Lin = anti-CD3, anti-CD4, anti-
CD8, anti-CD11b, anti-CD11c, Ter119, NK1.1, Gr-1), or (E) B220 after
gating on DN1 cells in (D). (E) red lines show Foxn1R/R; blue lines, WT. (F)
Flow cytometric analysis of E13.5 or E15.5 fetal thymic primordia with
anti-CD45-APC Cy7; anti-CD25-PE, and anti-CD44-APC. PN, postnatal;
WT, wild type. (E) shows pooled data from three 6 week old mice, n = 1.
All other data are representative of at least three separate analyses.
doi:10.1371/journal.pgen.1002348.g002
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Figure 3. Reduced Foxn1 expression results in impaired development of both medullary and cortical TEC in postnatal Foxn1R/R
thymi. (A-G, Ai-Hi) Immunohistochemical (A-E,G,H) and/or flow cytometric (Ai-Hi, F) analysis of postnatal Foxn1R/R thymi showing anti-CD205, Ly51, CDR1, anti-
Aire, anti-K14, anti-MHC Class II (MHCII), anti-Dll4, anti-ß5t, anti-PanK and anti-CD40 staining. (A–E,G,H) Right panels show co-stains of left panels, right Aire
panel shows detail from left panel. Scale bars 150 mm except for anti-CD205 and Ly51, which are 75 mm and Aire right panel which is 11.9 mm. (Ai-Hi, F) Plots
show data after gating against CD45+ and Ter119+ and for EpCam+ cells. Lower panel in Ei shows data after gating on CD45-EpCamlo cells (i.e. cTEC). Red lines,
Foxn1R/R; blue lines, WT (Foxn1R/+ rather thanWT is shown for Ly51, and is indistinguishable fromWT); grey lines, isotype control. All analyses are on 6 week old
thymi except E and Ei which are on postnatal day 10-11 thymi. Data shown are representative of at least three independent experiments, except (F), n=1. (I) 4
week old Foxn1R/R;ROSA26CreErt2 mice were injected intraperitoneally with 1.5 mg 4-hydroxy tamoxifen (4OHT) and sacrificed 2 days later; bottom panels show
un-injected littermate controls. Images show immunostaining with CDR1, anti-pancytokeratin, Ly51, anti-MHC Class II and anti-Aire. Data are representative of
at least 3 mice for each condition. (J) 6 week old Foxn1R/R;ROSA26CreErt2 (R/R) thymi were injected with 1.5mg 4OHT or carrier only and sacrificed 2 days later.
Controls were provided by uninjected Foxn1R/+;ROSA26CreErt2 (R/+) littermates. Frozen sections were stained with anti-Aire and anti-PanK, as in (I), and the
numbers of Aire+ TEC per mm2 of medullary area were determined by counting for three medullary areas from two sections from each of three mice for each
condition. Untreated R/R versus R/+, p=0.022; 4OHT-treated R/R versus R/+, p=0.28; 4OHT-treated R/R versus untreated R/R, p=0.025. (K) Mature and
immature postnatal cTEC (EpCAM+Ly51+MHC Class IIhi and EpCAM+Ly51+MHC Class IIlo cells respectively) and mTEC (EpCAM+Ly51-MHC Class IIhi and
EpCAM+Ly51-MHC Class IIlo cells respectively) were purified from 4-8 week old WT C57BL/6 mice by flow cytometry and the relative Foxn1 mRNA expression
levels in each cell population determined by QRT-PCR. Foxn1 is expressed at higher levels in WT cTEC than WT mTEC, and at higher levels in mature than in
immature TEC in both compartments. Foxn1 expression levels are shown relative to alpha-tubulin and are normalized to MHC Class IIhi cTEC. Data shown are
the mean of two technical replicates and are representative of three independent experiments. Error bars show SD.
doi:10.1371/journal.pgen.1002348.g003
Foxn1 Regulation of Thymic Epithelial Cells
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tamoxifen (4OHT) to induce Cre recombinase activity. Two days
after 4OHT injection, Foxn1 mRNA expression was restored to at
least WT levels (Figure S3) and Ly51, CDR1 and MHC Class II
staining was observed in a high proportion of cTEC (Figure 3I, see
also Figure S3).Dll4mRNA expression was also up-regulated by two
days post-injection, as was expression of both CCL25 and Cathepsin L
mRNA (Figure S3). Since the half-life of cTEC has been established
as 10-14 days [42] these data cannot be explained by proliferation of
a previously inhibited cell type followed by differentiation, but rather
must reflect phenotypic conversion of existing cells. They are
therefore consistent with release of a block in terminal differentiation.
The proportions of Aire+ mTEC were also restored to WT levels in
this experiment (Figure 3I, 3J).
Collectively, these data reveal two important and previously
unreported roles of Foxn1. First, although the requirement for
Foxn1 for postnatal TEC maintenance has recently been
demonstrated [26], this is the first report of a role for Foxn1 in
regulating the differentiation of postnatal TEC. Our data establish
the requirement for this transcription factor for terminal
differentiation of both cTEC and Aire+ mTEC in the postnatal
thymus. Since the Foxn1R/R phenotype is most severe in the
cortical compartment, they further suggest differential require-
ments for Foxn1 in the postnatal cortical and medullary TEC
compartments. Consistent with this idea, QRT-PCR analysis
indicated higher levels of Foxn1 mRNA in cortical than medullary
TEC in the normal postnatal thymus (Figure 3K). Second, they
also establish that Foxn1 regulates TEC-specific expression of
MHC Class II, Dll4, CD40 and Cathepsin L, which are all
critically required in TEC for execution of the T cell development
programme. While this regulation may be either direct or indirect,
it appears to be lymphocyte-independent, as all thymocyte subsets
are present in Foxn1R/R thymi.
Generation of an allelic series expressing graded levels of
Foxn1 mRNA
We next crossed Foxn1R/R mice with mice carrying the null
allele, Foxn1LacZ [13]. Foxn1LacZ phenocopies the original nude
mutation and is referred to as Foxn1- herein. Postnatal Foxn1R/-
mice had small, alymphoid thymic rudiments that were devoid of
any cortical or medullary organisation, and lacked peripheral T
cells (Figure 4A); no hematopoietic colonization of the Foxn1R/-
thymus was seen at any stage analyzed (Figure S4). Similar to
Foxn1nu/nu TEC [19] postnatal Foxn1R/- TEC were predomi-
nantly Plet-1+ and co-expressed Keratin 5 and Keratin 8, with
occasional cells expressing the cortical and medullary TEC
markers CDR1 and UEA1 respectively (Figure 4B). However,
unlike the hairless nu/nu or Foxn1-/- mice, Foxn1R/- mice
produced an overtly normal coat of hair up to six weeks of
age, after which they showed sporadic hair loss. Reactivation of
Foxn1 by tamoxifen-mediated induction of Cre recombinase
activity in postnatal Foxn1R/-; ROSA26CreERt2 mice up to at least
four months old resulted in development of an organized,
functional thymus containing all major cortical and medullary
TEC sub-types (Figure 4C), indicating that thymic epithelial
progenitor cells can persist for prolonged periods in vivo in the
absence of wild-type levels of Foxn1, and demonstrating that
expression of SV40Tag in these cells did not affect their
differentiative capacity.
The differences observed between Foxn1R/- and Foxn1-/- mice
suggested that further functions of Foxn1 might be revealed by
analysis of an allelic series. We therefore established a series of six
strains comprising all possible combinations of Foxn1-, Foxn1R and
WT alleles. Precise determination of Foxn1 mRNA expression
levels across this series relative to wild type was achieved by
analysis of a defined TEC population, E12.5 Plet-1+ TEC
(Figure 4D). In E12.5 Plet-1+ TEC, the Foxn1R allele expressed
approximately twenty percent of WT Foxn1 mRNA levels
(Figure 4D).
Foxn1 is not required for initial divergence of the
medullary TEC sub-lineage
The postnatal Foxn1 null phenotype is characterized by the
presence of linear aggregates of cells that express markers
associated with the earliest thymus-restricted epithelial progenitor
cells found in ontogeny [19], suggesting that, in the absence of
Foxn1, TE lineage progression might be blocked at the earliest
progenitor stage [19,13]. This idea was supported by the recent
demonstration of a persisting common TEPC in postnatal Foxn1-/-
mice [8]. However, the possibility remains that more restricted
precursors arise in the absence of Foxn1 but are not maintained
later in ontogeny.
To determine the stages in early thymus ontogeny at which
Foxn1 is required, we analyzed all strains of the allelic series
(Figure 5) using marker combinations that identify early cortex
(CD205 and K5lo/-) and early medulla (Claudin [Cldn] 4,
UEA1, K5hi and MTS10) [10,11,43,44]. Plet-1 [5] was also
included as an indicator of founder/early progenitor cell status.
We focussed on the E13.5 and E15.5 time points since at these
stages the TE is undergoing active patterning into cortical and
medullary compartments [45]. Notably, functional analyses
have shown that the Cldn4hi cells present at E13.5 in the WT
thymic primordium are medullary TE lineage-restricted pre-
cursors [10].
By E13.5 WT, Foxn1+/- and Foxn1R/+ thymi contained central
K5hiCldn4hi clusters surrounded by K5lo/-K8+Cldn4lo/- regions
(Figure 5A), as previously reported for WT thymi [3,10,45]; this
central Cldn4hi region has previously been demonstrated to
correspond to prospective medulla [10]. These data thus
confirmed the normal progression of TEC lineage development
in Foxn1R/+ mice.
K5hiCldn4hi and K5-Cldn4lo/- regions were also present in the
thymic primordia of Foxn1-/- mice at both E13.5 and E15.5
(Figure 5A; Figure S5). These data establish that divergence of the
mTEC lineage from the common TEPC occurs in the absence of
Foxn1 and is thus Foxn1-independent, in contrast to the existing
model of TE lineage development.
cTEC and mTEC differentiation was further probed using
markers expressed at various intermediate stages of TEC
development. Consistent with recent reports, neither CD205
[11] nor ß5t [40,46] were detected in Foxn1-/- mice at any
stage analyzed, confirming the dependence of the cortical sub-
lineage on Foxn1 at least from the onset of expression of these
markers. However, a CD205+ population was detectable by
E15.5 in all other strains tested, including Foxn1R/- mice,
demonstrating that only low levels of Foxn1 mRNA expression
are required to promote the early stages of cTEC development
(Figure 5B).
By E15.5, UEA1+ and MTS10+ mTEC were present in all
strains in the allelic series that express $50% WT levels of
Foxn1 mRNA (Foxn1+/-, Foxn1R/+ and WT thymi). However,
while strains that expressed #20% WT Foxn1 mRNA all
contained some UEA1+ TEC, MTS10 expression was not
detected (shown for Foxn1-/-, Foxn1R/R and Foxn1+/-, Figure 5C).
We note that UEA1 staining was present only on rare cells in
the Foxn1-/-and Foxn1R/- thymic primordium, but that this
staining was consistent and above background. Since MTS10
staining was detected as normal on postnatal mTEC in Foxn1R/
R mutants, but was only observed on very rare cells in postnatal
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Foxn1R/- and Foxn1-/- thymi, we conclude that mTEC
differentiation beyond the earliest mTEC sub-lineage progen-
itor state is blocked in the absence, and delayed at intermediate
levels, of Foxn1 expression.
Collectively, the data described above indicate that Foxn1 is not
required for divergence of the mTEC sub-lineage from the
common TEPC but is required subsequently, in a dosage
dependent manner, to promote TEC differentiation. Of note is
that high level Plet-1 expression is maintained in Foxn1-/- TECs,
supporting the conclusion that these cells remain blocked in the
earliest differentiation state despite having undergone lineage
divergence (Figure S5).
Figure 4. Quantitiative analysis of the Foxn1R allele. (A) Flow cytometric analysis of thymocyte development in neonatal Foxn1R/- mice.
Representative plots are shown for anti-CD45, anti-CD4 versus anti-CD8 and anti-CD44 versus anti-CD25, after gating on CD45+ cells. Foxn1R/- thymi
fail to support the maturation of immature thymocyte progenitors. Note that the tissue dissected in Foxn1R/- mice contains non-thymic tissue as well
as the thymic rudiment due to the difficulty of identifying the thymic rudiment in postnatal Foxn1R/- mice. (B) Immunohistochemical analysis of
postnatal Foxn1R/- and Foxn1-/- thymi showing Plet-1, CDR1, K14, K5, K8 and UEA-1 and PanK staining. Images shown are representative of at least
three individual mice for each genotype. Scale bars 47.62 mm for Plet-1/PanK and 150 mm for K5/K8, K14/CDR1 and UEA1/PanK. (C) 2-4 month old
Foxn1R/-;ROSA26CreErt2 mice were injected intraperitoneally with 1.5 mg 4-hydroxy tamoxifen (4OHT) or carrier, and sacrificed 7 weeks later. Thymi
were analyzed with the markers shown. MHCII, MHC Class II. (D) Relative Foxn1 expression levels were determined by QRT-PCR analysis of E12.5 Plet-1+
TEC using the Sybr-Green method. Foxn1 expression was normalized to the geometric mean of three housekeeping genes. Numbers show mean
expression level relative to WT. (A-C) Data shown are representative of at least three independent experiments. (D) WT, Foxn1R/+ and Foxn1R/R, data are
representative of at least three independent experiments; Foxn1R/- and Foxn1-/-, n = 1.
doi:10.1371/journal.pgen.1002348.g004
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Low-level Foxn1 expression enables exit from the earliest
sub-lineage TEPC states in the fetal thymus but is unable
to sustain lineage progression
The above analysis suggested that specific intermediate states of
TEC development are dependent on discrete levels of Foxn1
expression. To further test this notion, we used flow cytometry to
provide quantitative evaluation of TEC differentiation status in the
different allelic variants at defined time-points. For this we
analyzed representative markers of the founder TE cell-state
(Plet-1 [3,5]) and functional maturation (MHC Class II [47]); TEC
were positively identified using EpCam in all analyses.
In order to identify intermediate phenotypes that occur during
normal TEC lineage progression we initially analyzed expression
of these markers in WT mice at E12.5, E13.5 and E15.5
(Figure 5D). This demonstrated that normal TEC lineage
progression is characterized by the down-regulation of Plet-1
coupled with acquisition of MHC Class II expression.
We then analyzed the allelic series. This revealed that TEC
differentiation was delayed when Foxn1 expression was reduced,
and that the severity of the delay was inversely proportional to
Foxn1 mRNA level. In Foxn1R/R mice the TEC subset profiles at
E13.5 and E15.5 were equivalent to those of WT mice at E12.5
and E13.5 respectively (Figure 5E, 5F). Thus, normal TEC
differentiation occurred in the Foxn1R/R strain, but with delayed
kinetics.
The two functionally athymic strains (Foxn1R/- and Foxn1-/-)
each exhibited TEC subset profiles consistent with a severe early
block in TEC differentiation. Unexpectedly, the severity of this
block differed between these two strains. In Foxn1-/- thymi, the
ratio of Plet-1+ to Plet-1lo/- TEC was maintained between E13.5
and E15.5 and was similar to that observed at E12.5 during
normal development (determined based on comparison of the
mean percentage of Plet-1+ and Plet-1lo/- cells as shown in
Figure 5E, 5F legend). However, in Foxn1R/- thymi, the
proportion of Plet-1lo/- TEC increased from twenty six percent
at E13.5, comparable to E13.5 Foxn1-/- thymi, to forty one
percent at E15.5 (see mean percentages provided in Figure 5E,
5F legend). This suggested that by E15.5, at least some Foxn1R/-
TEC had been able to exit from the earliest progenitor state and
enter the TEC differentiation programme, but that Foxn1-/- TEC
could not make this transition. This conclusion was supported by
analysis of the differentiation marker MHC Class II, which was
expressed by a small population of Plet-1+ and Plet-1lo/- cells in
Foxn1R/- mice at E15.5, but was virtually undetectable in Foxn1-/-
mice (Figure 5F). Importantly, induction of MHC class II
expression occurred in the absence of colonizing haematopoietic
cells (Figure S4). Thus, while TECs in the Foxn1-/- thymus
remained in an undifferentiated state apparently equivalent to the
earliest progenitor stages of each TEC sub-lineage, Foxn1R/-
TECs could initiate the very early events associated with TEC
Figure 5. Divergence of the mTEC lineage is Foxn1-independent. Images show representative sections from (A) E13.5 thymic primordia after
staining for K5 and K8, Cldn4 and Plet-1. (B,C) E15.5 thymic primordia after staining for CD205 and panK (B) or MTS10, UEA-1 and panK (C). Scale bars
47.62 mm. Genotypes of embryos are as designated. Note that the medullary lineage markers Cldn4, K5 and UEA1 are expressed in Foxn1-/- thymi.
Bottom right image in (C) shows negative control (NC) for UEA1 stain (Streptavin-Alexa647). Data shown are representative of at least three independent
experiments. (D-F) Plots show staining of (D) wild type thymic primordia from E12.5, E13.5 and E15.5 mice, (E) E13.5 and (F) E15.5 mice of the genotypes
shown after staining with anti-Plet-1 (MTS20) and anti-MHC Class II (MHCII). All plots show data obtained after gating on EpCAM+ cells. The data shown
for Foxn1-/-, Foxn1+/-, and E13.5 Foxn1R/-mice are representative analyses of individual thymic primordia, all other plots show analyses on pooled samples
from several embryos. n$3 for all genotypes. Relative proportions of EpCam+Plet-1+ cells in Foxn1-/- and Foxn1R/- mice: E13.5: Foxn1R/-, 70.8616.0%;
Foxn1-/-, 74.367.6%. E15.5: Foxn1R/-, 5967.9%; Foxn1-/-, 73.8613.3%; Foxn1R/- versus Foxn1-/- p=0.74 (E13.5), p = 0.06 (E15.5).
doi:10.1371/journal.pgen.1002348.g005
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lineage differentiation but could not progress beyond this initial
differentiation step.
Foxn1 controls allocation into or maintenance of the
differentiated TEC compartment
Collectively, the above data establish that Foxn1 is required for
progression through successive stages of both cTEC and mTEC
differentiation. To test whether Foxn1 might also regulate TEC
proliferation and/or survival, we also quantified both founder/
early progenitor cells of the lineage (Plet-1+MHC Class II– TEC)
and cells that were further into the TE differentiation programme
(Plet-1- TEC) for each allelic variant.
At both E13.5 and E15.5, the absolute numbers of Plet-1+ cells
correlated with Foxn1 dosage (Figure 6A), consistent with a role
for Foxn1 in regulating proliferation of Plet-1+ TEC and thus
potentially overall thymus size [48]. However, the most marked
effect was on the numbers of Plet-1- TEC present at different levels
of Foxn1. At intermediate and low Foxn1 levels (i.e. #20% of WT
mRNA levels; Foxn1R/R, Foxn1R/- and Foxn1-/- mice) the numbers
of Plet-1- TEC were decreased by four-fold compared to Foxn1+/-
thymi at both E13.5 and E15.5. Notably, Foxn1 dosage was more
important in determining Plet-1+ and Plet-1- cell numbers than the
presence or absence of SV40Tag (Figure 6A). These data establish
that a threshold level of Foxn1 mRNA between that found in
Foxn1R/R and Foxn1+/- TEC is required for generation/expansion
of the Plet-1- TEC population with normal kinetics, indicating a
role for Foxn1 in regulating thymus size.
The above data could be consistent with roles for Foxn1 in the
production, proliferation and/or maintenance of Plet-1- TEC. To
begin to discriminate between these possibilities we performed cell
cycle analysis on TEC in all of the allelic variants at E15.5. Both
Foxn1R/- and Foxn1-/- TEC exhibited slower cell cycle times than
WT TEC (Figure 6B; note the proportions of cells in the G1/G0
and S/G2/M fractions). However, no differences in cell cycle were
observed between E15.5 WT, Foxn1R/+ and Foxn1R/R TEC
(Figure 6B: note the proportions of cells in G0/G1, S and G2/
M), establishing that the reduced Plet-1- cell numbers in fetal
Foxn1R/R thymi could not be explained by differences in
proliferation rate. We therefore conclude that in the fetal thymus,
Foxn1 regulates allocation of cells into the differentiating Plet-1-
TEC compartment and/or the maintenance of Plet-1- TEC. At
present, we cannot distinguish between direct and indirect effects
of Foxn1 in regulating fetal Plet-1- cell numbers, as we also
observed a significant delay in maturation of the thymic
mesenchyme and immigration of mesenchymal cells into the
thymic epithelium in Foxn1R/R mice (Figure S6), raising the
possibility that the deficit in Plet-1- TEC in these mutants at E15.5
might reflect impaired mesenchymal-epithelial cross talk.
Foxn1 regulates effector genes with diverse roles in
thymic epithelial cell development and function
In order to relate our findings to molecular control of TEC
differentiation and function, we investigated the response of a
suite of genes with diverse functions in thymus biology – i.e. that
are known to regulate particular aspects of thymus development
or are required in TEC to support T cell development - to
changes in Foxn1 dosage. In this panel, we included genes known
to be down-regulated or absent from the Foxn1 null thymic
primordium or identified in our analysis as being regulated by
Foxn1 (Dll4 [34] and CCL25 [49]), or with defined roles in TEC
development (Pax 1 [50-52]). We also included Fgf2, to date the
only gene verified by chromatin immunoprecipitation in
keratinocytes as a direct Foxn1 target [53]. Expression of each
gene was analyzed at two time points. Initially, we analyzed
expression in EpCam+ cells purified from the thymic primordium
at E13.5. QRT-PCR analysis revealed that all of the genes tested
except Fgf2 showed changes in expression in response to Foxn1
levels (Figure 6C-6E and 6C’-6D’; see also Figure S3). In this
population, Dll4, CCL25 and Pax1 were each expressed in
proportion to Foxn1 mRNA levels, though titrating to different
threshold levels (Figure 6C, 6D). Our data indicate considerable
heterogeneity among E13.5 TEC, raising the possibility that the
observed expression patterns reflected altered TEC subset
balances between the different allelic variants. Therefore, we
also analyzed expression of these genes in a defined cell
population, E12.5 Plet1+ TEC. The expression levels of all three
genes were also proportional to Foxn1 expression in this
population (Figure 6 C’ and D’), indicating that, in TEC, Foxn1
is genetically upstream of all three genes. In contrast, EpCam was
expressed at comparable levels in the E12.5 Plet1+ TEC
population in all of the allelic variants. Surprisingly Fgf2
expression was detected in thymic mesenchyme but not in
TEC, indicating that Foxn1 regulates different targets in TEC
and keratinocytes (Figure 6F). To test whether Foxn1 regulation
of Dll4 and CCL25 was direct or indirect, we over-expressed
either the full-length Foxn1 cDNA or GFP cDNA in a cell
population that does not normally express Foxn1 or either Dll4 or
CCL25. Both genes were significantly up-regulated in cells
transfected with Foxn1 but not in control samples (Figure 6G).
These data thus strongly suggest that Foxn1 directly regulates both
Dll4 and CCL25.
In conjunction with the data presented above showing Foxn1
regulates multiple intermediate TEC states, these data suggest that
Foxn1 is a master regulator of the overall ‘thymus programme’
rather than regulating a particular aspect of TEC biology.
Discussion
We have investigated the role of Foxn1 in the TE lineage via
analysis of an allelic series that expresses defined levels of Foxn1
mRNA relative to WT. We have demonstrated that, in early
ontogeny, Foxn1 is not required for divergence of the medullary
TE sub-lineage from the common thymic epithelial progenitor
cell; indeed we found no evidence for Foxn1 regulation of the
choice between two alternative cell fates at any point in TE lineage
progression. We have further demonstrated the requirement for
Foxn1 for stable initiation of differentiation in the earliest TEC
progenitors present in ontogeny, for subsequent progression
through intermediate progenitor stages in both the cortical and
medullary TEC sub-lineages, and for terminal differentiation of
both cTEC and mTEC in the postnatal thymus. Taken together,
these data establish that Foxn1 is required to execute the TE
lineage programme at multiple stages in both the cortical and
medullary TEC sub-lineages, but does not appear to regulate cell
fate choice in TE lineage development. A model for Foxn1
regulation of cellular hierarchies during TE lineage development,
based on the genetic analyses presented herein, is proposed in
Figure 7.
In addition, we have established that Foxn1 is genetically
upstream of a number of genes with known roles in TE lineage
development or TEC function, specifically Pax1, Dll4, CD40,
Cathepsin L and MHC Class II, demonstrating that Foxn1 regulates
these genes either directly or indirectly. Finally, we have confirmed
and extended observations that Foxn1 is required indirectly to
regulate thymic mesenchymal development [54]. These findings
significantly extend understanding of regulation of thymus
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Figure 6. Foxn1 is required for exit from the earliest TEC progenitor states and regulates the size of the differentiated TEC
compartment during ontogeny. (A) Absolute numbers of Plet-1+ EpCam+MHC Class II- (MHCII)(open bars) and Plet-1-EpCam+ (black bars) cells per
thymus at E13.5 and E15.5 for each genotype. Data shown are representative of at least three independent experiments. Error bars show SD. (B) Cell
cycle analysis of Foxn1 allelic variants. Images show flow cytometric analysis of E15.5 WT, Foxn1R/+, Foxn1R/R, Foxn1R/- and Foxn1-/- thymi using anti-
BrdU-APC and 7-AAD 1 hour after injection with BrdU. Plots are representative plots for each genotype after gating on EpCam+ cells; pairs of plots
show data collected on the same day. (C,D,F) QRT-PCR analysis of E13.5 TEC (EpCam+ cells) or E13.5 thymic mesenchymal cells (PDGFRalpha+ cells) for
the genes shown. Data are normalized to alpha-tubulin and shown relative to E13.5 WT EpCam+ cells (C,D) or E13.5 WT PDGFRalpha+ cells (F) and
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development and function by this key transcription factor, and
pave the way for molecular dissection of these processes.
Role of Foxn1 in TE lineage progression
With respect to TE lineage development during thymus
organogenesis, our data (Figure 5) establish that Foxn1 is not
required for divergence of the medullary TE sub-lineage from the
common TEPC that is currently thought to exist at the basis of the
TEC hierarchy [8]. This finding was unexpected, particularly given
the recent demonstration of a persisting common TEPC in Foxn1
null mice [8]. Taken together with those of Bleul and colleagues, our
data strongly suggest that only the common TEPC can persist in the
postnatal Foxn1 null thymus and thus that Foxn1 is required directly
or indirectly for TEC survival at stages subsequent to the common
TEPC (including sub-lineage restricted progenitors). However,
further work is required to explore this hypothesis, as an alternative
possibility is that the activity of sub-lineage progenitors could not be
detected in the clonal assay employed by Bleul.
Our data further establish that, subsequent to lineage
divergence, Foxn1 is required in the fetal thymus for stable exit
from the earliest progenitor cell state/entry into the differentiation
programme leading to generation of functional TEC in both the
cortical and medullary sub-lineages. Strikingly, low-level expres-
sion of Foxn1 (as found in Foxn1R/- TEC) is sufficient to initiate or
stabilize entry into the TEC differentiation programme, as
evidenced by acquisition of MHC Class II staining (see Figure 6),
but is not sufficient to promote differentiation to a stage at
which TEC in either sub-lineage are able to support T cell
development. These data collectively establish that entry into
the TE differentiation programme can be genetically separated
from execution of the full programme (i.e. the programme lead-
ing to TEC that are functionally competent to support T cell
development) based on different threshold expression levels of
Foxn1. This indicates the requirement for Foxn1 for mediating
both processes, and will enable dissection of the molecular role of
Foxn1 at early and late differentiation stages.
We have also demonstrated, to our knowledge for the first time,
that Foxn1 regulates differentiation of both cTEC and mTEC sub-
lineages in the postnatal thymus. Specifically, we have shown that at
intermediate levels of Foxn1 expression (as found in Foxn1R/R TEC)
differentiation of cTEC is blocked at a CD205+CDR1- develop-
mental stage and in addition, the number of Aire+ mTEC are
significantly decreased. That the block in cTEC differentiation is
relieved within two days of reversion to WT Foxn1 levels provides
genetic evidence for the existence of the CD205+CDR1- interme-
diate stage in cortical TEC differentiation previously suggested by
indirect analyses [11] and extends those findings from the fetal to
the postnatal thymus. That the number of Aire+ mTEC is also
rapidly restored to WT levels upon reversion of the Foxn1R allele
suggests that differentiation of mTEC is also blocked at intermediate
Foxn1 levels. From these data, we conclude that Foxn1 regulates
similar mechanisms in each of the major TEC sub-lineages.
Our data further indicate MHC Class II as a direct or indirect
target of Foxn1 in both fetal and postnatal TEC. Notably, TEC
are unique outside the hematopoietic system in constitutively
expressing MHC Class II, and the link between Foxn1 and MHC
Class II expression is therefore significant.
Foxn1 regulation of genes required for TEC development
or function
Finally, we have demonstrated that Foxn1 directly or indirectly
regulates a panel of genes that mediate diverse aspects of thymus
development or function. These include Pax1, an essential mediator
of TEC differentiation/survival [52]. Pax1 is expressed in the third
pharyngeal pouch from E9.5 and remains expressed throughout
thymus ontogeny, being restricted to cTEC in the postnatal thymus
[50]. Although regulation of this Pax gene is only poorly understood,
from E11.0 sustained expression of Pax1 requires Hoxa3 [55]. Our
data show, to our knowledge for the first time, that expression of
Pax1 in the thymic primordium is Foxn1-dependent. They thus
place Foxn1 and Hoxa3 together in a network or cascade that
regulates Pax1 expression, providing the first demonstration of a
genetic interaction between Hoxa3 and Foxn1 (Figure 6H). In this
regard, it is striking that Hoxa3+/-Pax1-/-compound mutant mice
share some phenotype characteristics with Foxn1R/R mice; both
mutants have hypomorphic postnatal thymi and reduced levels of
MHC class II expression on TEC [51]. As Hoxa3 itself is expressed
in TEC in all of the Foxn1 mutants at E13.5 (data not shown), our
data could support either of two alternative explanations: Hoxa3
may regulate Foxn1, which in turn regulates Pax1 expression in the
thymic primordium, such that Hoxa3 regulation of Pax1 is Foxn1-
dependent (Figure 6Gi), or Hoxa3 and Foxn1 may be required
independently to maintain Pax1 expression in the third pharyngeal
pouch/early thymus primordium (Figure 6Gii). We note that since
Hoxa3 is expressed both in TEC and neural crest-derived
mesenchymal cells in the thymic primordium, its regulation of
Pax1 could be either direct or indirect.
We further show that Foxn1 regulates CCL25 and Dll4, which
each play critical roles in thymocyte development – CCL25
regulates colonization of the fetal thymus [49] while Dll4 is the
obligate Notch ligand controlling commitment of haematopoietic
progenitors to the T cell lineage [34] respectively. It has previously
been suggested, based on antibody staining, that although Dll4
and CCL25 are absent from the Foxn1 null thymus [56] their
expression is Foxn1-independent in TEC [57]. However, this view
has been challenged in a recent report, which placed Foxn1
upstream of dll4a and ccl25a expression in medaka fish [58]. Our
data show that in both early fetal TEC and in the postnatal thymus
Dll4 expression is proportional to Foxn1 expression, and further
demonstrate that over-expression of Foxn1 in embryonic stem cells
results in expression of both Dll4 and CCL25. They therefore
extend the findings in medaka to demonstrate Foxn1 regulation of
Dll4 and CCL25 in the mammalian thymus, and provide strong
evidence that Foxn1 regulation of both of these target genes is
direct. Reduced expression of Dll4 in Foxn1R/R mutants also
correlates with a proportional increase in intrathymic B cells,
indicating that Foxn1 expression within the normal range is
necessary to sustain full TEC functionality. Taken together, these
data provide mechanistic insight into our findings that Foxn1
show the means from two (Pax1) or three (Dll4, CCL25, Fgf2) biological replicates for each gene. Data for all genes are representative of at least three
biological replicates performed using either the Lightcycler or Fluidigm platforms. Error bars show SD. (C’,D’,E) QRT-PCR analysis of E12.5 Plet1+ TEC
for the genes shown. Data are normalized to EVA [64] and shown relative to E12.5 WT Plet1+ cells. Data show mean of three technical replicates from
one experiment on RNA from pooled thymi for each genotype. CCL25 and Dll4, data are representative of two independent analyses using different
analysis platforms. (G) QRT-PCR analysis of mouse embryonic stem cells after transient transfection with either Foxn1 or GFP. Data show Foxn1, Dll4
and CCL25 expression levels relative to ß actin and show means of two (Foxn1) or three (Dll4, CCL25) biological repeats. Error bars show SD. Dll4,
p = 0.009 (Foxn1 over-expression versus GFP over-expression); CCL25 p=0.038 (Foxn1 over-expression versus GFP over-expression). (H) Cartoon
shows regulatory network indicated by data shown.
doi:10.1371/journal.pgen.1002348.g006
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regulates multiple aspects of TEC development and function. As
they demonstrate Foxn1 regulation of genes required for many
different aspects of TEC biology, they suggest that this
transcription factor functions a master regulator of the core
TEC lineage programme. Furthermore, the finding that different
Foxn1-regulated genes show distinct response patterns to changes
in Foxn1 dosage may explain why different levels of Foxn1 are
required for different functions in TEC.
Collectively, the data presented herein establish Foxn1 as
powerful regulator of TEC differentiation in the fetal and adult
thymus. Furthermore, they demonstrate that different threshold
levels of Foxn1 mRNA are required for different functions.
Together with the recent finding that reduction of Foxn1
expression postnatally causes premature thymic involution
characterized by loss of TEC [25-27], this suggests that Foxn1
may be required in TEC from initiation of differentiation
throughout the cell’s lifetime. Further work is required to
determine whether it is a maintenance factor for differentiated
TEC as well as having roles in proliferation and differentiation.
Improved understanding of the regulation of Foxn1 in thymic
development and homeostasis, and of Foxn1 regulation of its
targets in different TEC sub-types, is thus likely to become a
priority for strategies aimed at protecting or regenerating the
thymus for therapeutic ends.
Materials and Methods
Ethics statement
All animal work was conducted according to UK Home Office
guidelines, as established in the ANIMALS (SCIENTIFIC
PROCEDURES) ACT 1986.
Mice
Rosa26CreERt2/+ [41] and ZP3-Cre [28] mice were maintained as
homozygotes and crossed with Foxn1R/R mice as described.
Foxn1-/- mice [59] were maintained as heterozygotes on a
C57BL/6 background. Foxn1R mice were backcrossed onto the
C57BL/6 background for at least 5 generations and subsequently
maintained via intercrossing. For timed matings, noon of the day
of the vaginal plug was taken as day 0.5.
Generation of Foxn1 targeting vector
A construct containing the targeting cassette shown in Figure S1
was generated by standard molecular biology techniques and verified
by sequencing. Conventional subcloning was used for the majority of
cloning steps. PCR cloning using a proof-reading Taq polymerase
(Roche) and TOPO-TA cloning vector (Invitrogen) was employed to
insert the SV40 T antigen cassette. RecET cloning [60] was used to
isolate 4 kb of the mouse Foxn1 locus from PAC367b19.
Figure 7. Foxn1 regulation of TE lineage development. Model of cellular hierarchies in TEC lineage progression based on the genetic data
presented. The dotted lines represent lineage transitions in which the precursor-progeny relationship is currently uncertain.
doi:10.1371/journal.pgen.1002348.g007
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Southern blotting
Genomic DNA was processed for Southern Blotting as
described [61].
Gene targeting and blastocyst injection
Mouse sv129/ola ES cells (line E14tg2a) were electroporated
with linearized targeting vector and grown under Blasticidin
selection. Three correctly targeted clones, identified by Southern
analysis (Figure S1), were expanded and transfected with a Cre
recombinase expression plasmid to induce deletion of the BSD
cassette. Clones in which this cassette had been deleted, but which
retained the rest of the targeting construct including the two
remaining LoxP sites, were identified by Southern analysis,
verified by sequencing and injected into C57BL/6 blastocysts to
generate chimeric mice. Germ-line transmission was confirmed by
genotyping for two independently targeted ES cell clones.
Transient transfection
E14Tg2a cells were cultured in GMEM containing FCS and
LIF. Transfection was carried out in 12 well plates, at a cell density
of 90-95% confluence, using GeneJuice transfection reagent
(Novagen). The ratio of transfection reagent to DNA was 5:1
and 1 mg of DNA was used for each well. The medium was
changed 24 hrs after transfection and 1.5 mg/ml Puromycin was
added to the new medium to select for transfected cells. Cells were
harvested 48 hours after transfection.
Primers
The sequences of primers used for conventional PCR and
QRT-PCR are shown in Table 1 and Table 2 respectively.
Genotyping
Foxn1F and Foxn1R were used to detect the wild-type Foxn1
allele. TF and TR were used to detect the SV40 T antigen cDNA.
Antibodies
MTS20 (IgM) and MTS24 (IgG2a), rat mAbs that recognise Plet-
1 [5], and MTS10, a rat mAb that recognises medullary TEC, were
kind gifts from R.L. Boyd; anti-EpCAM (G8.8, rat IgG2a, DSHB);
anti-Cytokeratin 8 (Troma 1, rat IgG2a, DSHB); anti-Cytokeratin
14 (LL002, mouse IgG3 was a kind gift from E.B. Lane); anti-
Cytokeratin 5 (AF138, rabbit IgG, Covance); anti-Claudin 4 (rabbit
IgG was a kind gift from S. Tsukita); anti-Dll4 was a kind gift from F.
Radtke; anti-CD3-FITC (145-2C11, hamster IgG1); anti-CD4-
FITC or PE (H129.19, rat IgG2a); anti-CD8-FITC (53-6.7, rat
IgG2a); anti-CD11b-FITC (M1/70, rat IgG2b); anti-CD11c-FITC
(HL3, hamster IgG1); anti-a-CD19-FITC (1D3, rat IgG2a); anti-
CD25-PE (3C7, rat IgG2b); anti-CD44-APC (1M7, rat IgG2b); anti-
Ly76-FITC (Ter119, rat IgG2b); anti-CD31-FITC or purified (390,
rat IgG2a); anti-CD45-APC (30-F11, rat IgG2b); anti-PDGFRalpha
(APA-5, rat IgG2a); anti-SV40 T antigen (PAb100, mouse IgG1)(all
Pharmingen); ERTR7 (rat IgG2a was a kind gift fromW. van Ewijk);
anti-Cytokeratin (rabbit IgG polyclonal, DAKO); CDR1 (Rat
IgG2a, was a kind gift from B Kyewski); anti-Foxn1 C-terminal
(IMG-3744, polyclonal, Imgenex); Ly51 (Clone 6C3, Rat IgG2a,
Biolegend); anti-ß5t (Rabbit polyclonal, purified, IgG, MBL
International); biotinlyated UEA-1 (Vector Laboratories). For
detection of unconjugated primaries the following secondary
antibodies were used; goat anti-rabbit IgG-alexa488; goat anti-rat
IgG-alexa647; goat anti-rat IgG-alexa488; goat anti-mouse IgG-
alexa647; donkey anti-rat IgG-alexa488; Streptavidin-alexa647 (all
Molecular Probes); mouse anti-rat IgM-PE (G53-238, Pharmingen).
Flow cytometry
Analysis. Mouse fetal thymi were processed for flow cytometric
analysis as described [3]. Adult TEC were enzymatically digested to
single cell suspensions as described for fetal thymi, and processed for
flow cytometric analysis without further enrichment. Adult
thymocytes were isolated by mechanical disruption of 5–6 week
old thymi and stained with the appropriate antibodies. All staining
was for 20 minutes on ice in PBS/5%FCS/5U/ml DNAseI. Data
were acquired using a FACS Cailibur (BD San Jose, Ca) or Cyan
(Beckman Coulter, Miami, Fl) cytometers and analyzed using Flowjo
version 6.4.6 (Tree Star, Inc) software.
Sorting. For isolation of fetal TEC, MTS20+CD45-Ter119-
CD31-PDGFRalpha- and MTS20-CD45-Ter119-CD31-PDGFR
alpha- populations were purified; anti-EpCam was also used to
positively identify TEC in some sorts (as indicated). For isolation of
adult TEC, TEC were enriched as described [62] and
EpCAM+Ly51+MHC Class IIhi, EpCAM+Ly51+MHC Class IIlo,
EpCAM+Ly51-MHC Class IIhi, and EpCAM+Ly51-MHC Class
Table 2. Primer sequences used for QRT-PCR.
Gene name Primer sequence
alpha-tubulin forward 59 CGGACCACTTCAAGGACTAAA 39
alpha-tubulin reverse 59 ATTGCCGATCTGGACACC 39
Foxn1 forward 59 TGACGGAGCACTTCCCTTAC 39
Foxn1 reverse 59 GACAGGTTATGGCGAACAGAA 39
Dll4 forward 59 AGGTGCCACTTCGGTTACAC 39
Dll4 reverse 59 GGGAGAGCAAATGGCTGATA 39
CCL25 forward 59 GAGTGCCACCCTAGGTCATC 39
CCL25 reverse 59 CCAGCTGGTGCTTACTCTGA 39
Pax1 forward 59 CTCCGCACATTCAGTCAGC 39
Pax1 reverse 59 TCTTCCATCTTGGGGGAGTA 39
Fgf2 forward 59 CGGCTCTACTGCAAGAACG 39
Fgf2 reverse 59 TGCTTGGAGTTGTAGTTTGACG 39
Cathepsin L forward 59 CAAATAAGAATAAATATTGGCTTGTCA 39
Cathepsin L reverse 59 TGTAGCCTTCCATACCCCATT 39
EpCam forward 59 AGAATACTGTCATTTGCTCCAAACT 39
EpCam reverse 59 GTTCTGGATCGCCCCTTC 39
EVA forward 59 TGTGCTTCCACTTCTCCTGA 39
EVA reverse 59 TCCACAGCTTCTGTAGGACAAA 39
doi:10.1371/journal.pgen.1002348.t002
Table 1. Primer sequences used for conventional PCR.
Gene name Primer sequence
Foxn1 forward (Foxn1F) 59 CATAATCCCAGCACGTGGG 39
Foxn1 reverse (Foxn1R) 59 GGGCGCTGAGAGAGTGAAATG 39
Foxn1 Exon 1A forward (Ex1AF) 59 GACGGTCGGAGCTCCTGGC 39
Foxn1 Exon 3 reverse (Ex3R) 59 CTCTGCTGGGAAGCTAGGC 39
SV40TAg forward (TF) 59 TGCCTAAAACACTGCAGGCC 39
SV40Tag reverse (TR) 59 TGAAATTTGTGATGCTATTGC 39
ß actin forward 59 GGCCCAGAGCAAGAGAGGTATCC 39
ß actin reverse 59 ACGCACGATTTCCCTCTCAGC 39
doi:10.1371/journal.pgen.1002348.t001
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IIlo populations purified after gating against CD45-Ter119- cells.
Cell sorting was performed using MoFlo (Dakocytomation) and
FACSAria (BD) cell sorters, to a purity of .95% for each sample.
For all samples, compensations were determined using antibody
capture beads (made in house by S. Monard) and Fluorescence
Minus One (FMO) staining was used to determine positivity for
each antibody. 7AAD was used to identify dead cells in all samples.
Immunohistochemistry
Whole E13.5 – E15.5 embryos or adult thymi were processed
for immunohistochemistry as described [2]. Isotype controls (not
shown) were included in all experiments. Staining was analyzed
using a Leica AOBS confocal microscope (Leica Microsystems
GmbH). The images presented are either single optical sections or
projected focus stacks of serial optical sections. The number of
Aire+ TEC per mm medullary area was established by analyzing
three medullary areas on each of two non-sequential sections from
each of three individual mice (i.e. the number of Aire+ cells was
counted for six different medullary areas for each of three
individual mice per condition). The size of each medullary area
was calculated using Adobe Photoshop and the number of Aire+
cells per square mm was then calculated. Statistical analysis was on
the average number of Aire+ cells per condition.
Tamoxifen injection
Mice were treated with a single intraperitoneal injection of
1.5 mg 4-hydroxy tamoxifen (4OHT) prepared in ethanol and
diluted appropriately in Cremophor (Sigma)/PBS.
RNA isolation
RNA was prepared using Tri-reagent and RNAeasy (both
Qiagen) according to manufacturer’s instructions. All samples
were DNase treated.
QRT-PCR
cDNA was prepared using the Superscript II first strand
synthesis kit (Invitrogen) with Oligo-dT primers, according to
manufacturer’s instructions. For data shown in Figure 4, the IQ
SYBR Green Supermix (Bio-Rad) was used for quantification
and the relative expression level of the target genes was
normalized to the geometric mean of three control genes (Hprt,
Ywhaz, Hmbs). For data shown in Figure 3, Figure 6C, 6D, 6F
and 6G, Figure S2 and Figure S3, relative expression levels were
determined using the Roche Universal Probe Library (Foxn1,
Probe 68; SV40Tag, Probe 32; alpha-tubulin, probe 58; Dll4,
probe 106; CCL25, probe 9; Pax1, probe 105; Fgf2, probe 4;
EpCam, probe 52; EVA, probe 100) with the Roche Lightcycler
480. Relative expression levels are shown after normalization to
alpha-tubulin expression using Roche LC480 Relative Quantifica-
tion software. Technical duplicates or triplicates were run for all
samples and no RT and no template controls were included in all
experiments. For data shown in Figure 6C’, 6D’ and 6E, relative
expression levels were determined using the Roche Universal
Probe Library (as above) using microfluidic QRT-PCR (Flui-
digm). Pre-amplification was carried out using target specific
primer pairs according to the manufacturer’s protocol. Samples
were loaded onto a BioMark 48.48 Dynamic Array (Fluidigm)
and thermal cycling was performed using a BioMark instrument
(Fluidigm) according to the manufacturer’s protocol. Data
analysis was carried out using BioMark Real-Time PCR Analysis
Software v2.0 (Fluidigm) and the DCt method [63]. Expression
levels are shown relative to WT after normalization to Epithelial
V-like Antigen (EVA)[64].
Cell cycle analysis
Pregnant female mice were injected with 1mg BrdU at E15.5
and embryos were collected 1 hour after injection. Thymi were
immediately microdissected, dissociated and stained with G8.8
(Pharmingen), anti-CD45-PE, anti-BrdU-APC and 7-AAD using
the Pharmingen APC BrdU Flow Kit according to manufacturer’s
instructions.
Western blotting
Nuclear protein fractions were prepared using the Active Motif
Nuclear Extract Kit according to manufacturer’s instructions,
separated by electrophoresis on a SDS-PAGE gel (Novex,
Invitrogen), and processed for Western Blotting as described [5].
Statistical analysis
Statistical analysis was performed using the one-way ANOVA test
(two tailed), as appropriate for normally distributed data (normal
distribution was tested using Chi2 goodness of fit). The alpha level is
taken as 0.05. Errors shown are standard deviations throughout.
Sample sizes of at least n= 3 were used for statistical analyses.
Supporting Information
Figure S1 Generation of Foxn1R mice, related to Figure 1. (A) A
LoxP flanked cassette containing the following elements: the 59
engrailed 2 splice acceptor site (SA), the SV40TAg coding region,
and internal ribosome entry site coupled to an enhanced green
fluorescent protein/neomycin resistance fusion protein (IRES-
EGFPneo), the CMAZ transcriptional pause and a LoxP flanked
Blasticidin-S deaminase (BSD) resistance gene was inserted into
intron 1b of the Foxn1 locus of mouse ES cells by conventional
gene targeting methods. E, exon. (B) Blasticidin resistant colonies
were isolated and screened by Southern blotting of Nde1 digested
genomic DNA using 59 and 39 flanking probes as indicated.
Correctly targeted clones yielded 7.5kb and 5.3kb bands
corresponding to the wild-type and targeted alleles respectively
when screened with the 59 probe, and 7.5kb and 9.3kb bands
corresponding to the wild-type and targeted alleles respectively
when screened with the 39 probe. (C, D) To remove the BSD
selectable marker targeted ES cell clones were electroporated with
a Cre expression vector to allow the transient expression of Cre
recombinase and thus excision of the floxed BSD cassette.
Following transfection, cells were plated at clonal density,
expanded and transferred to master and duplicate plates.
Blasticidin sensitive colonies were screened by Southern blotting
of Nde1 digested genomic DNA using the 39 flanking probe to
identify clones in which only the BSD cassette had been removed.
Clones in which this event had occurred yielded an 8.3kb band in
addition to the 7.5kb band corresponding to the wild-type allele.
Three independent clones were identified and subsequently
injected into C57BL/6 blastocysts to generate chimeras. Of four
high contribution chimeras tested two produced agouti coloured
offspring, indicating that the ES cells had contributed to the
germline. This was confirmed by genotyping. The transgenic line,
designated Foxn1R, was back-crossed onto the C57BL/6 back-
ground and subsequently maintained as homozygotes. Genotypes
are indicated above each image. Foxn1R/R thymi exhibit a relative
decrease in Foxn1 protein levels compared to wild-type and
Foxn1R/+ thymi. wt, wild-type; R/+, Foxn1R/+; R/R, Foxn1R/R.
(TIF)
Figure S2 SV40Tag is expressed at low levels from the Foxn1
locus in Foxn1R/R TEC in vivo. (A) Image shows staining for
SV40Tag (Tag) and pancytokeratin (PanK) in the MC2x3a
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(MC2x3) cell line, which was established from E12.5 TEC from
Foxn1R/R mice. The line was passaged for several months before
analysis. (B) Image shows staining for SV40Tag, pancytokeratin
and DAPI on postnatal thymus sections from Foxn1R/R mice. No
SV40Tag staining was ever detected on thymus sections, despite
analyzing mice of different ages and using different staining
protocols. (C) QRT-PCR analysis of cells from the MC2x3a cell
line, and purified EpCam+ TEC from 6 week old Foxn1R/R and
WT mice. Data shown are relative to alpha-tubulin. TEC were
isolated as described in Materials and Methods.
(TIF)
Figure S3 Relative mRNA expression in postnatal WT and
Foxn1R/R UEA1-EpCam+ TEC and in Foxn1R/R;R26CreERt2
UEA1-EpCam+ TEC 2 days after 4OHT injection. Thymi from
three 4-week old mice from each genotype (WT, Foxn1R/R and
4OHT-treated Foxn1R/R;R26CreERt2) were dissected and processed
for flow cytometric cell sorting after enrichment for CD45- cells by
AutoMACS, as described in Materials and Methods. Since
Foxn1R/R cTEC express low levels or no Ly51 and CDR1, in
order to enrich for cTEC, we purified EpCam+UEA1- cells.
CD205 was not used since, in our hands, CD205 does not stain all
Ly51+ cTEC. The purified EpCam+UEA1- cells for each genotype
were pooled and processed for QRT-PCR analysis of Foxn1, Dll4,
CCL25 and Cathepsin L as described in Materials and Methods.
Data shown are relative to alpha-tubulin and are normalized to WT
(n=1).
(TIF)
Figure S4 Lack of colonisation of the fetal Foxn1R/- thymic
primordium by hematopoietic cells. Images show immunohisto-
chemical analysis of E13.5 thymi showing anti-CD45 (red) and
anti-PanK (green) for each genotype as indicated. CD45+ cells can
be seen within the thymic epithelium in Foxn1R/R mice but are
reduced in number compared to Foxn1R/+ controls. CD45+ cells in
Foxn1R/- mice remain localized to peri-thymic areas and fail to
migrate into the thymic epithelium. Scale bars 47.62 mm.
Representative of at least three separate analyses.
(TIF)
Figure S5 Effect of Foxn1 dosage on TEC development during
ontogeny. Images show representative sections from E13.5 or
E15.5 thymic primordia after staining for (A) K5 and K8, and (B)
Plet-1 (MTS24) and panK. Scale bars 47.62 mm. Genotypes are as
indicated. Data shown are representative of at least three
independent experiments.
(TIF)
Figure S6 Regulation of thymic mesenchymal development by
Foxn1. A) Images show transverse sections of E15.5 thymi stained
with a-PDGFRalpha, ERTR7 and PanK as indicated. Genotypes
are as shown. Immigration of ERT7+ mesenchyme into the
thymus primordium is impaired in Foxn1R/R, Foxn1R/- and Foxn1-/-
mice. Scale bars, 47.62 mm. (B) Flow cytometric analysis of whole
E15.5 thymi. Plots show staining with a-PDGFRalpha and anti-
PDGFRß after gating on EpCam-CD45- cells. PDGFRalpha+ cells
represent an increased proportion of total thymic mesenchyme in
the Foxn1 hypomorphic mutants compared to Foxn1R/+ controls
and the hypomorphic mutants also express higher levels of
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